We are live on ! Find out more
BLTE

Belite Bio
BLTE

15 hedge funds and large institutions have $3.69M invested in Belite Bio in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

36% more funds holding

Funds holding: 11 → 15 (+4)

0.36% less ownership

Funds ownership: 0.61% → 0.26% (-0.36%)

57% less capital invested

Capital invested by funds: $8.52M → $3.69M (-$4.83M)

Holders
15
Holders Change
+4
Holders Change %
+36.36%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$647K
2
Marshall Wace
Marshall Wace
United Kingdom
+$411K
3
Citadel Advisors
Citadel Advisors
Florida
+$313K
4
JP Morgan Chase
JP Morgan Chase
New York
+$304K
5
XT
XTX Topco
Cayman Islands
+$261K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$6.76M
2
HF
HRT Financial
New York
-$247K
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$122K
4
Morgan Stanley
Morgan Stanley
New York
-$18.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
1
State Street
Massachusetts
$942K +$214K +4,415 +28%
Bank of America
2
Bank of America
North Carolina
$631K +$647K +13,349 +13,087%
Marshall Wace
3
Marshall Wace
United Kingdom
$398K +$411K +8,486 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$314K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$303K +$313K +6,460 New
JP Morgan Chase
6
JP Morgan Chase
New York
$298K +$304K +6,268 +7,123%
XT
7
XTX Topco
Cayman Islands
$253K +$261K +5,394 New
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$225K -$122K -2,511 -34%
CSS
9
Cubist Systematic Strategies
Connecticut
$94.7K +$97.9K +2,019 New
VEA
10
Virtus ETF Advisers
New York
$86.4K +$1.75K +36 +2%
RhumbLine Advisers
11
RhumbLine Advisers
Massachusetts
$67.3K +$69.6K +1,435 New
GI
12
GAMMA Investing
California
$40.8K +$21.5K +443 +104%
Morgan Stanley
13
Morgan Stanley
New York
$31K -$18.5K -382 -37%
UBS Group
14
UBS Group
Switzerland
$6K +$6.2K +128 New
Osaic Holdings
15
Osaic Holdings
Arizona
$375 – – –
AC
16
Armistice Capital
New York
– -$6.76M -148,000 Closed
HF
17
HRT Financial
New York
– -$247K -5,409 Closed

BLTE Hedge Fund Activity: Q3 2024 in Review

15 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q3 2024, worth a combined $3.69M — down 57% from $8.52M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BLTE positions and 2 closed out — a net gain of 4 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Bank of America, adding an estimated $647K. The largest seller was Armistice Capital, exiting entirely with an estimated $6.76M sold.

  • 15 institutional investors held Belite Bio (BLTE) as of Q3 2024, up from 11 in Q2 2024.
  • Funds reported $3.69M of Belite Bio stock for Q3 2024, down 57% quarter-over-quarter.
  • 6 funds opened new Belite Bio positions in Q3 2024 and 2 closed out, a net change of +4 holders.
  • The largest Belite Bio buyer in Q3 2024 was Bank of America, an estimated $647K added.
  • The largest Belite Bio seller in Q3 2024 was Armistice Capital, an estimated $6.76M sold.

Based on aggregated 13F filings for Q3 2024.